Perkutane Koronarinterventionen zusätzlich zur optimalen medikamentösen Therapie bei stabiler Angina Pectoris

Autor: Gorenoi, Vitali, Schönermark, Matthias P., Hagen, Anja

Publikováno v: GMS Health Technology Assessment, Vol 7, p Doc07 (2011)
GMS Health Technology Assessment; VOL: 7; DOC07 /20111110/
GMS Health Technology Assessment

Scientific background Stable Angina Pectoris (AP) is a main syndrome of chronic coronary artery disease (CAD), a disease with enormous epidemiological and health economic relevance. Medical therapy and percutaneous coronary interventions (PCI) are th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59d4fa7f2487cccbd48dcf8126bb0985
http://www.egms.de/en/journals/hta/2011-7/hta000098.shtml

Spezifische Immuntherapie (SIT) zur Behandlung der allergischen Rhinitis

Autor: Gorenoi, Vitali, Hagen, Anja, Schönermark, Matthias P.

Publikováno v: GMS Health Technology Assessment; VOL: 6; DOC01 /20100316/
GMS Health Technology Assessment
GMS Health Technology Assessment, Vol 6, p Doc01 (2010)

Scientific background Allergic rhinitis (AR) exhibits a prevalence of approx. 20% in Germany and causes enormous costs in the health care system. Specific immunotherapy (SIT) is considered to be the only potentially causal therapy for AR and mainly a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d361a5051946aa3ea2e56f2eb65ae891
http://www.egms.de/en/journals/hta/2010-6/hta000079.shtml

Arthroplasty register for Germany

Autor: Gorenoi, V, Schönermark, MP, Hagen, A

Publikováno v: GMS Health Technology Assessment; VOL: 5; DOC13 /20091002/

Scientific background The annual number of joint replacement operations in Germany is high. The introduction of an arthroplasty register promises an important contribution to the improvement of the quality of patient's care. Research questions The pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1175::bb5789fc005d1e2b150397a34bfdc538
http://nbn-resolving.de/urn:nbn:de:0183-hta0000759

Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events

Autor: Schnell-Inderst, P, Schwarzer, R, Göhler, A, Grandi, N, Grabein, K, Stollenwerk, B, Klauß, V, Wasem, J, Siebert, U

Publikováno v: GMS Health Technology Assessment; VOL: 5; DOC06 /20090512/

Background In a substantial portion of patients (= 25%) with coronary heart disease (CHD), a myocardial infarction or sudden cardiac death without prior symptoms is the first manifestation of disease. The use of new risk predictors for CHD such as th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1175::d793e3a4befba9f190144ec7531afff6
http://www.egms.de/en/journals/hta/2009-5/hta000068.shtml

Intravascular brachytherapy for peripheral vascular disease

Autor: Gorenoi, V, Dintsios, CM, Schönermark, MP, Hagen, A

Publikováno v: GMS Health Technology Assessment; VOL: 4; DOC08 /20080903/

Scientific background Percutaneous transluminal angioplasties (PTA) through balloon dilatation with or without stenting, i.e. vessel expansion through balloons with or without of implantation of small tubes, called stents, are used in the treatment o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1175::3b591732a5325aeda05868395848a413
http://www.egms.de/en/journals/hta/2008-4/hta000057.shtml